AI
AJU IB Investment Co., Ltd.
High-turnover trader
Total reported value
—
Reporting period: 2026-06-30 · Number of holdings: 1
AJU IB Investment Co., Ltd. disclosed 1 holdings in its latest 13F filing for the period ending 2026-06-30, with total reported value of — and a quarterly turnover rate of 100.0%.
Personality snowflake
- Concentration
- 0
- Portfolio Stability
- 100
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 2
- Sizing Uniformity
- —
Recent moves
Sold out ACLXGBX
Sold out KYMR
Sold out SEER
Sold out RLYB
Sold out STRO
Sold out XLO
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | Stock-Other | — | — | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-06-30 | 1 | — | 100 | |
| 2026-03-31 | 6 | $30.5M | 66 | |
| 2025-12-31 | 7 | $22.8M | 100 | |
| 2025-09-30 | 7 | $115.1M | 100 | |
| 2025-06-30 | 8 | $91.9M | 0 | |
| 2025-03-31 | 8 | $84.0M | 100 | |
| 2024-12-31 | 8 | $102.8M | 100 | |
| 2022-09-30 | 7 | $58.4M | 0 | |
| 2022-06-30 | 7 | $51.6M | 0 | |
| 2022-03-31 | 7 | $64.8M | 0 | |
| 2021-12-31 | 6 | $71.8M | 0 | |
| 2021-09-30 | 11 | $155.0M | 0 | |
| 2021-06-30 | 11 | $173.4M | 100 | |
| 2021-03-31 | 11 | $265.1M | 32 | |
| 2020-12-31 | 11 | $264.3M | — |
Holding changes this quarter
AJU IB Investment Co., Ltd.'s most significant position changes for 2026-06-30: Sold out: Arcellx INC (ACLXGBX); Sold out: Kymera Therapeutics INC (KYMR); Sold out: Seer INC (SEER); Sold out: Rallybio CORP (RLYB); Sold out: Sutro Biopharma, Inc. (STRO).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | — | EXIT | Sold out |
| 2 | KYMR | Kymera Therapeutics INC | — | EXIT | Sold out |
| 3 | SEER | Seer INC | — | EXIT | Sold out |
| 4 | RLYB | Rallybio CORP | — | EXIT | Sold out |
| 5 | STRO | Sutro Biopharma, Inc. | — | EXIT | Sold out |
| 6 | XLO | Xilio Therapeutics INC | — | EXIT | Sold out |
| 7 | ✓ | Ikena Oncology INC | — | — | Unchanged |
FAQ
What is AJU IB Investment Co., Ltd. and what type of investor is it?
AJU IB Investment Co., Ltd. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-06-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are AJU IB Investment Co., Ltd.'s largest equity positions?
Based on the latest 13F filing, AJU IB Investment Co., Ltd.'s top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did AJU IB Investment Co., Ltd. make in its most recent portfolio filing?
In the latest quarter, AJU IB Investment Co., Ltd. took a more defensive posture — trimming 0 positions and completely exiting 6 holdings. The largest of these moves: Sold out: Arcellx INC (ACLXGBX); Sold out: Kymera Therapeutics INC (KYMR); Sold out: Seer INC (SEER); Sold out: Rallybio CORP (RLYB); Sold out: Sutro Biopharma, Inc. (STRO)
What sectors does AJU IB Investment Co., Ltd. focus on?
Sector breakdown data is not yet available for AJU IB Investment Co., Ltd.. Check back after the next 13F processing cycle.